Top Navigation - USA

News
Events
Careers
Investors
Compliance

Healthcare Professionals
Patients & Caregivers
About AtriCure

AtriCure Rings the Opening Bell

Along with the many accomplishments to celebrate this year, AtriCure visits the Nasdaq MarketSite in Times Square to ring the opening bell and is proud to celebrate its 25th anniversary!

Learn About AtriCure

LeAAPS Trial Completes Enrollment

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction (LeAAPS) Clinical Trial has completed enrollment

Learn More

The Next Generation AtriClip Device

The AtriClip PRO-Mini Device is designed to optimize visualization of the left atrial appendage (LAA) for minimally invasive procedures.

Learn More

Top Workplaces 2025

Ready to work at a Top Workplace?

Learn About Opportunities

0

Patients Served with Ablation Worldwide

0

AtriClip Devices Sold Worldwide

U.S. NEWS

AtriCure to Participate in the 2025 Wells Fargo Healthcare Conference

READ THE RELEASE

REDUCING GLOBAL AFIB

What is Afib, and how does it affect heart performance?

LEARN ABOUT AFIB

CAREERS

Interested in joining our mission to reduce the global Afib epidemic?

SEARCH AVAILABLE OPPORTUNITIES

THERAPY INNOVATION

Post-Operative Pain Management: A non-opioid solution

DISCOVER CRYO NERVE BLOCK

LinkedIn
YouTube
Facebook

AtriCure, Inc. @AtriCure.• 08.26.2025

We celebrate the voices, talents and leadership of women across AtriCure and around the world. With 49% of our workforce made up of women, we’re proud of the powerful contributions they make—driving innovation, shaping our culture and improving the lives of millions of patients globally. #WomensEqualityDay

JUMP TO POST

AtriCure, Inc. @AtriCure.• 08.25.2025

Designed with precision in mind, the Isolator® Synergy™ Clamp delivers consistent, full-thickness lesions with confidence. Discover the first and only approved surgical device to treat Afib at: https://okt.to/hWH8Qr #CardiacSurgery #Afib

JUMP TO POST

AtriCure, Inc. @AtriCure.• 08.24.2025

We are looking for an experienced and strategic Compliance Director to lead medical device healthcare compliance initiatives across North, Central, and South America. This role is ideal for a dynamic leader with deep expertise in risk management, regulatory strategy, and cross-functional collaboration. If you're ready to make an impact within a fast-growing and innovative organization, we’d love to connect! https://okt.to/FQcYwp #Hiring

JUMP TO POST

AtriCure, Inc. @AtriCure.• 08.23.2025

With 60% less volume than the next smallest surgical LAAM device, the AtriClip Mini is available for both MIS and open procedures, providing surgeons optimized visibility during placement. Discover the latest innovation: https://okt.to/17dwlq #AtriClip #LAAE

JUMP TO POST

AtriCure: Impacting Lives, One Patient at a Time

Duration: 4:5

JUMP TO POST

AtriClip FLEX∙V® Device Animation

Duration: 2:9

JUMP TO POST

AtriClip PRO2® Device Animation: Mini AVR Procedure with LAA Occlusion

Duration: 3:47

JUMP TO POST

Mechanism of Action Comparison AOD vs AOD2 AtriClip Devices

Duration: 1:25

JUMP TO POST

AtriCure, Inc. @AtriCure.• 26 Aug 2025

JUMP TO POST

AtriCure, Inc. @AtriCure.• 22 Aug 2025

The Advancing Health Gallery at the Cincinnati Museum Center continues to ignite curiosity and deepen understanding of the human body through its interactive exhibits. AtriCure is proud to support the CMC’s heart exhibit and lead an annual outreach series including exhibit days and summer camps that deliver hands-on learning experiences designed to educate, empower and inspire the next generation of innovators. #STEM #Innovation

JUMP TO POST

AtriCure, Inc. @AtriCure.• 20 Aug 2025

Over 3 million people in the U.S. live with Inappropriate Sinus Tachycardia (IST). For those who are symptomatic and unable to tolerate medications, the HEAL-IST Trial is now enrolling. This clinical study is evaluating the safety and effectiveness of a hybrid sinus node-sparing ablation procedure as a potential treatment option. Learn more about the trial and patient qualifications at: HEAL- IST.com #InappropriateSinusTachycardia #IST #ClinicalTrial

JUMP TO POST

AtriCure, Inc. @AtriCure.• 19 Aug 2025

Dr. David Caparelli recently spoke with CBS News about how Cryo Nerve Block is reshaping recovery for his cardiac patients. By temporarily freezing nerves during surgery, #cryoNB can reduce pain for months after the procedure and help patients get back to life with greater comfort. In the interview, Dr. Caparelli shares how patients like David are experiencing less pain and a smoother recovery journey. Watch the story here: https://okt.to/HZvxNa #PainManagement Important Safety Indications: https://okt.to/8l5iwU

JUMP TO POST

08.25.2025, AtriCure, Inc. @AtriCure

JUMP TO POST

08.23.2025, AtriCure, Inc. @AtriCure

JUMP TO POST

08.22.2025, AtriCure, Inc. @AtriCure

Treating Afib during cardiac surgery isn’t just recommended—it has Class I support. Yet it’s still often skipped. Addressing Afib at the time of surgery can make a big difference in long-term outcomes. Learn more at https://t.co/yRVO8etTN5 #Afib #CardioTwitter

JUMP TO POST

08.21.2025, AtriCure, Inc. @AtriCure

Fast. Focused. Efficient. The cryoSPHERE® MAX delivers targeted cryoablation in just 60 seconds, providing a quick and effective solution for post-operative pain management. Surgeons can help patients trade pain for numbness and support a smoother recovery. Discover how: